{"id":521919,"date":"2021-08-03T07:04:05","date_gmt":"2021-08-03T11:04:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/"},"modified":"2021-08-03T07:04:05","modified_gmt":"2021-08-03T11:04:05","slug":"hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/","title":{"rendered":"HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK and VIENNA, Austria, Aug.  03, 2021  (GLOBE NEWSWIRE) &#8212; HOOKIPA Pharma Inc. (NASDAQ: HOOK, \u2018HOOKIPA\u2019), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that it will release second quarter 2021 financial results and recent highlights before the market opens on Thursday, August 12, 2021.<\/p>\n<p align=\"justify\">The Company will not be conducting a conference call in conjunction with this earnings release.<\/p>\n<p align=\"justify\">\n        <strong>About HOOKIPA<\/strong><br \/>\n        <br \/>HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies that mobilize and amplify targeted T cells and antibodies, the body\u2019s natural infection killers, to fight or prevent serious disease.<\/p>\n<p align=\"justify\">HOOKIPA is developing a broad pipeline of potential first-in-class arenaviral immunotherapies in oncology and infectious disease. We are leveraging our proprietary, versatile platform to engineer arenaviral therapeutics that induce robust antigen-specific CD8+ T cells and pathogen-neutralizing antibodies to a broad range of self and non-self antigens, including viral antigens, tumor-associated antigens and neoantigens. Our immunotherapies are designed to use either non-replicating or replicating viral vectors based on the target disease, with the potential to induce CD8+ T cell response levels previously not achieved by other immunotherapy approaches.<\/p>\n<p align=\"justify\">HOOKIPA\u2019s pipeline include ongoing clinical trials in Human Papilloma Virus 16-positive cancers and Cytomegalovirus, as well as preclinical research in prostate cancer, HIV and Hepatitis B. The latter two are in collaboration with Gilead Sciences, Inc.<\/p>\n<p align=\"justify\">Find out more about HOOKIPA online at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MIerzDvs4cgEIm2GSUsOhnK8Mfi0W9aTqG2jdQvs_hyzZllTiu4YBY8vQPeQOIzZ9uuehF1YhwHzoI51ihUfBcMQdxSM_RMESAuakuo4PTc=\" rel=\"nofollow noopener\" target=\"_blank\">www.hookipapharma.com<\/a>.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:35%;width:35%;min-width:35%\">For further information, please contact:<\/td>\n<td style=\"max-width:65%;width:65%;min-width:65%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td>\n            <strong>Media<\/strong>\n          <\/td>\n<td>\n            <strong>Investors<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>Nina Waibel<\/td>\n<td>Matt Beck<\/td>\n<\/tr>\n<tr>\n<td>Senior Director &#8211; Communications<\/td>\n<td>Executive Director &#8211; Investor Relations<\/td>\n<\/tr>\n<tr>\n<td>\n            <a href=\"mailto:nina.waibel@hookipapharma.com\" rel=\"nofollow noopener\" target=\"_blank\">nina.waibel@hookipapharma.com<\/a>\n          <\/td>\n<td>\n            <a href=\"mailto:matthew.beck@hookipapharma.com\" rel=\"nofollow noopener\" target=\"_blank\">matthew.beck@hookipapharma.com<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTYyNCM0MzM3OTg0IzIxNTY5MjI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/67d07ce6-ef46-4ba9-a590-db2852f42a75\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK and VIENNA, Austria, Aug. 03, 2021 (GLOBE NEWSWIRE) &#8212; HOOKIPA Pharma Inc. (NASDAQ: HOOK, \u2018HOOKIPA\u2019), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that it will release second quarter 2021 financial results and recent highlights before the market opens on Thursday, August 12, 2021. The Company will not be conducting a conference call in conjunction with this earnings release. About HOOKIPA HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies that mobilize and amplify targeted T cells and antibodies, the body\u2019s natural infection killers, to fight or prevent serious disease. HOOKIPA is developing a broad pipeline of potential first-in-class arenaviral immunotherapies in oncology and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-521919","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK and VIENNA, Austria, Aug. 03, 2021 (GLOBE NEWSWIRE) &#8212; HOOKIPA Pharma Inc. (NASDAQ: HOOK, \u2018HOOKIPA\u2019), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that it will release second quarter 2021 financial results and recent highlights before the market opens on Thursday, August 12, 2021. The Company will not be conducting a conference call in conjunction with this earnings release. About HOOKIPA HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies that mobilize and amplify targeted T cells and antibodies, the body\u2019s natural infection killers, to fight or prevent serious disease. HOOKIPA is developing a broad pipeline of potential first-in-class arenaviral immunotherapies in oncology and &hellip; Continue reading &quot;HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-03T11:04:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTYyNCM0MzM3OTg0IzIxNTY5MjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021\",\"datePublished\":\"2021-08-03T11:04:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\\\/\"},\"wordCount\":275,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTYyNCM0MzM3OTg0IzIxNTY5MjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\\\/\",\"name\":\"HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTYyNCM0MzM3OTg0IzIxNTY5MjI=\",\"datePublished\":\"2021-08-03T11:04:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTYyNCM0MzM3OTg0IzIxNTY5MjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTYyNCM0MzM3OTg0IzIxNTY5MjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/","og_locale":"en_US","og_type":"article","og_title":"HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021 - Market Newsdesk","og_description":"NEW YORK and VIENNA, Austria, Aug. 03, 2021 (GLOBE NEWSWIRE) &#8212; HOOKIPA Pharma Inc. (NASDAQ: HOOK, \u2018HOOKIPA\u2019), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that it will release second quarter 2021 financial results and recent highlights before the market opens on Thursday, August 12, 2021. The Company will not be conducting a conference call in conjunction with this earnings release. About HOOKIPA HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies that mobilize and amplify targeted T cells and antibodies, the body\u2019s natural infection killers, to fight or prevent serious disease. HOOKIPA is developing a broad pipeline of potential first-in-class arenaviral immunotherapies in oncology and &hellip; Continue reading \"HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-03T11:04:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTYyNCM0MzM3OTg0IzIxNTY5MjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021","datePublished":"2021-08-03T11:04:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/"},"wordCount":275,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTYyNCM0MzM3OTg0IzIxNTY5MjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/","name":"HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTYyNCM0MzM3OTg0IzIxNTY5MjI=","datePublished":"2021-08-03T11:04:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTYyNCM0MzM3OTg0IzIxNTY5MjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTYyNCM0MzM3OTg0IzIxNTY5MjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-report-second-quarter-2021-financial-results-on-thursday-august-12-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"HOOKIPA Pharma to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521919","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=521919"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521919\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=521919"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=521919"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=521919"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}